Emami Q4 Review – Stellar Performance Continues: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Emami Ltd.’s Q4 FY21 results were ahead of our estimates.

Domestic business jumped 44%, while international business posted 28% revenue growth in Q4.

All categories reported strong double digit growth on favourable base.

Boroplus jumped five times (77% decline in Q4 FY20) as supply led constraints are addressed completely.

The company launched 40 plus new products during FY21.

New products development contributes 4% of domestic revenues.

International business posted 28% growth driven by 14% increase in South Asian Association for Regional Co-operation and 53% growth in Middle East, North Africa, Afghanistan, and Pakistan.

Click on the attachment to read the full report:

Dolat Capital Emami Q4FY21 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Most Related Links :
editorpen Governmental News Finance News

Source link

Back to top button